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Suppressor cells have been shown to be involved in the regulation of immune responses 
m  genetic nonresponder animals (1,  2),  as well as in those animals which have been 
tolerized to certain antigens (3, 4). Cells exhibiting  suppressor activity have been recently 
identified in the spleens of tumor-bearing  hosts (5, 6). These cells were able to nonspecifi- 
cally suppress a variety of immune responses by normal syngeneic cells. It is not known 
whether this type of suppression observed in tumor-bearing animals involves immuno- 
logical mechanisms such as those responsible in the antigen systems described above, or 
whether the suppression is due to overloading the immune system of the host with tumor 
cells. 
The present report examines the roles of suppressor cells during host-tumor 
interaction in which the tumor is rejected, as well as that during a progressively 
growing lesion in an unresponsive mouse strain.  Using a spontaneously derived 
AKR/J carcinoma-like tumor,1 differential growth patterns were observed in the 
parental  AKR/J, as compared to (AKR/J  ×  DBA/2)F1 and  (AKR/J  ×  C57BL/ 
6)F1 hybrids.  This study demonstrates that depression of immune responsive- 
ness  and  the  generation  of suppressor  cells,  appears  to  correlate  with  the 
strength  or weakness of the  specific anti-tumor  responses in these strains  of 
mice. 
Materials and Methods 
Mice.  6- to  8-wk-old male AKR/J,  (AKR/J  ×  DBA/2)F~, and (AKR/J  x  C57BL/6)F~ were 
purchased from The Jackson Laboratory, Bar Harbor, Maine, and housed in animal rooms at the 
Immunology Branch, NIH, Bethesda, Md. 
Tumors.  All animals were injected subcutaneously  with 5 × 10  e AKR/J carcinoma-like tumor 
cells ~  in Hanks' balanced salt solution at a total vol of 0.25 ml. At 10-12 days postinjection, the 
size of the tumors in the AKR/J and AKB6F~ were approximately equal (10-12 mm diameter), 
while that in the AKD2F~ was somewhat larger (15-18 mm). 
In Vitro Generation of Antibody Responses.  Responding spleen cells were cultured for 3 or 4 
days with trinitrophenyl-lipopolysaccharide (TNP-LPS)  or sheep  erythrocytes (SRBC), respec- 
tively, in 96-well flat bottom Microtest II plates (Falcon Plastics, Div.  of BioQuest,  Oxnard, 
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Calif.).  Specific  plaque-forming  cells  (PFC)  per  10  7 cultured  spleen  cells  were  measured  as 
previously described. 2 
In  Vitro  Generation  of Cytotoxic  Responses.  Responding  spleen  cells  were  incubated with 
irradiated (10,000 rads) syngeneic AKR/J tumor cells or 2,000 rads irradiated allogeneic spleen 
cells as described elsewhere. 2 After 5 days of incubation, effector cells were harvested and assayed 
for specific cell-mediated cytotoxicity. 
Cytotoxic Assay.  Target cells,  L5MF-22 (H-2 b) lymphoma, PS15-Y  (H-2  ~) mastocytoma,  and 
AKR/J (H-2 k) carcinoma-like cells were labeled with 51Cr and incubated at 37°C in 5% CO2 with 
effector cells for 4-5 h  as described elsewhere2 The percentage specific release of 51Cr was calcu- 
lated as follows: 
experimental cpm -  control cpm  ×  100. 
total cpm freeze-thaw -  background cpm 
Results and  Discussion 
Spleen  cells from  AKR/J,  AKD2F1,  and  AKB6F1  mice  were  sensitized  in 
vitro against AKR/J tumor cells. The results in Table I show that AKB6F1 and 
AKR/J, but not AKD2F, spleen cells were able to generate specific anti-tumor 
effector  cells.  The  secondary  cell-mediated  anti-tumor  responses,  in  which 
spleen  cells from  mice preimmunized  with  5  x  10  6 viable tumor  cells  were 
sensitized against the same tumor in culture, showed similar results. 3 These in 
vitro findings correlated with the in vivo growth pattern of the tumor in these 
strains.  Thus, the ADK2F1 hybrid, which did not reject the tumor in vivo, also 
appears  to be unable to respond  effectively against  the tumor in vitro.  The 
AKR/J  and  AKB6F1  animals,  which  generated  a  successful  anti-tumor  re- 
sponse in vivo, were also capable of effecting a significant cell-mediated anti- 
tumor response in vitro. Thus, the H-2 d allele appeared to be associated with 
susceptibility, whereas the H-2 k  and H-2 b alleles were associated with resist- 
ance. It is noteworthy that the strongest anti-tumor responses were associated 
with the H-2 b allele, 3 which has previously been found to be associated with 
strong resistance to murineleukemia virus-induced neoplasms (7). 
The data in Table II illustrate that the splenic lymphocytes of tumor-bearing 
(12 day) AKR/J and AKD2F~ mice were markedly depressed in their ability to 
generate allogeneic effector cells after a primary in vitro sensitization against 
the relevant  antigens.  In  contrast,  the  AKB6F1 spleen cells did not demon- 
strate  any depression  in their  ability to elicit  such  a  response.  Mixtures  of 
spleen cells from tumor-bearing mice of all three strains  with normal synge- 
neic spleen cells failed to demonstrate any "true" suppressive activity, i.e., the 
decreased  level  of response  in  these  cultures  could  be  accounted  for  by  a 
dilution effect of the unresponsive population  (Table II).  We have also found 
that depression of mixed lymphocyte and mitogen reactivity follows a similar 
pattern  in  these  strains. 4 Thus,  the  cellular  immune  reactivity  in  12-day 
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TABLE I 
Cytotoxicity of Spleen Cells From Normal AKR/J, AKB6F,, and AKD2F, 
Mice Sensitized In Vitro Against AKR/J Tumor Cells 
Responding spleen 
cells  and  H.2  haplo- 
types 
Specific cytotc~lclty  ±  SE assayed on targets: 
AKR/J CARC (H-2  k)  LSMF-22 (H-2  ~) 
25:1  50:1  100 1  100:1 
AKR/J (H-2  A)  5.2  ±  1.3  7.6  ±  0  3  10 2  -+  0  8  1 7  ±  0.4 
AKB6F~ (H-2k'~  ND*  17 8  -*  0  5  21  5  ±  1 4  -0  8  ±  1 1 
AKD2F~ (I'l.2  ~'n)  ND  -0.77  ±  0.5  0.56  ±  0 4  1 2  ±  1.1 
5.5-h 5~Cr-release  assay at effector:target  rahos shown; spontaneous release:  AKR/J CARC,  12.2%, L5MF-22, 
8 8% 
* ND, not done 
TABLE  II 
Ability  of Tumor-Bearing  AKR/J,  AKB6F~,  and  AKD2F1  Mice  to Generate Allogeneic 
Cytotoxic Effector  Cells In  Vitro 
% Specific cytotoxlcity  _+  SE assayed on targets: 
Responding spleen  Stlmulatmg  RDM-4 
cells  (× 10  s)  spleen cells  L5MF.22 (H-2b#  P815-Y (H.2  ~)  (H.2k) 
(1  x  106) 
2:1  4:1  8:1  2'1  4.1  8:1  8.1 
7.0 Normal AKPJJ  C57BL/10 (H-2  b)  39.6  ±  1 3  58.4  ±  1.0  72 6  ±  1.1  -  -  12.0  ±  1 8  5 4  _+  1 1 
7 0  Tumor AKR/J  C57BL/10 (H-2  b)  2 2 +- 0.5  3.8  ±  0  5  5.2  ±  1.0  -  -  0.4  ±  1.2  0  1  -*  0  7 
3  5  Normal  AKR/J  +  C57BL/10 (H-2  b)  18 4  ±  1.0  31.9  ±  2.3  48.1  ±  1.9  -  -  2  1  ±  0.9  - 
3.5 tumor AKR/J 
7.0 Normal AKD2F~  C57BL/10 (H-2  b)  29.1  -*  1 4  37 4  ±  0.7  54.7  ±  3.5  -  --  7.9  -+  0 6  1,8  ±  1.1 
7 0  Tumor AKD2F~  C57BL/10 (H-2  b)  2.7  ±  0.8  4.8  ±  0.7  5.9  ±  0.7  -  -  -0,6  ±  0.9  -0.3  ±  0.9 
3.5 Normal AKD2F~ +  C57BL/10 (H-2  b)  12.2  ±  1.0  16.7  ±  0.7  28.0  ±  1 4  -  -  1.6  ±  1 0  0.5  ±  1 2 
3  5  tumor  AKD2F~ 
7 0 Normal AKB6F]  BI0.D2 (H-2  d)  -  -  3 0 -* 0.6  33 4 ±  1.4  48.9 ±  1 9  63.6 ± 2 0  2.9 _+ 1 0 
7.0 Tumor AKB6F,  B10.D2 (H-2  ~)  -  -  6.6  ±  1 2  68.5  ±  1 0  82.2  ±  4.4  89.9  ±  1.8  2.9  ±  1.4 
4-h 5'Cr-release  assay at effector:target  rahos shown; spontaneous release.  L5MF-22, 6.3%; P815-Y, 11.6%, and RDM-4, 10.5%. 
posttumor injected  AKR/J,  as  well  as  the  unresponsive  AKD2F1  mice  was 
found to be markedly depressed, but suppressive activity, capable of inhibiting 
these responses by normal populations, was not demonstrable. 
Similar to the depression observed in the aforementioned responses, we also 
found  (Fig.  1 A)  that  AKR/J  and  ADK2F~  spleen  cells from  12-day  tumor- 
bearing hosts were strikingly deficient in their ability to generate direct PFC's 
to both  T-dependent  (SRBC)  and  T-independent  (TNP-LPS)  antigens  after 
primary  in vitro sensitization.  The  highly  responsive  AKB6FI  strain  again 
displayed  no depression  in its  ability  to produce PFC's to either of the two 
immunogens.  When spleen cells from the AKR/J and ADK2F1  animals were 
mixed with their respective syngeneic normal spleen populations  (Fig.  1 B), 
the direct PFC responses of these cultures to both SRBC and TNP-LPS were 
suppressed to levels similar to that of the unresponsive spleen cells. Therefore, 
unlike  the  cell-mediated  response  to  allogeneic  spleen  cells,  antibody  re- 
sponses elicited by spleen cells from normal mice could be suppressed by spleen 
cells from tumor-bearing AKR/J and AKD2F, hosts. 
There  are  several  interpretations  which  could  explain  the  finding  that 
antibody responses, but not cell-mediated sensitization, could be suppressed by 1366  LEVY  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIO.  1.  Comparison of the generation of primary PFC responses in vitro by spleen cells 
from  normal  and  tumor-bearing AKR/J,  AKD2FI,  and  AKB6F2  mice.  (A)  Direct  PFC 
response to  SRBC.  (B)  Direct PFC  response to TNP-LPS  (assayed on TNP-SRBC).  The 
numbers shown on the bars indicate the number of plaques read per slide on duplicate 
slides. PFC detected in controls (unsensitized, cultured cells for A and B; and sensitized, 
cultured cells assayed on noncross-reacting erythrocyte targets for B) were not more than 
5% of the experimental values. 
spleen cells from tumor-bearing AKR/J and  AKD2F1  mice.  The  suppressor 
population generated could be specific for antibody-forming cell precursors or 
helpers, but not effector cell precursor populations. Although suppressor cells 
in other systems (5, 6) have been reported to inhibit both types of responses, it 
was not conclusively determined whether a single population was responsible. 
The suppression of antibody production in tumor-bearing AKR/J mice could 
prevent the accumulation of blocking factors (8), thereby increasing the effect 
of the host's cell-mediated rejection processes. A second explanation could be 
attributable to a difference in the susceptibility to suppression of the two types 
of responses. This could mean that  a  qualitatively single population of sup- 
pressors is capable of suppressing both antibody- and cell-mediated responses, 
but that the latter becomes susceptible only when significant levels of these 
cells are generated.  We have recently found  4 that in the unresponsive AKD2F1 
strain,  suppressor cells which inhibit primary sensitizations of normal synge- 
neic  spleen  cells  against  alloantigens  appeared  during  a  period  of tumor 
growth after that when cells able to suppress antibody responses were demon- 
strable. 
Cantor et al. have recently shown that the generation of suppressive activity 
in response to erythrocyte antigens is directly proportional to the amount of 
immunizing  antigen  (3). Helper activity of spleen cells from hyperimmune 
animals was drastically lower than that of similar cells from optimally immu- LEVY  ET  AL.  BRIEF  DEFINITIVE  REPORT  1367 
nized  mice  (4).  The  level of antibody response may therefore depend on the 
porportion of T-helper and T-suppressor cells produced. Thus, a shift in favor of 
the latter,  for example,  might result in a  state of overall  unresponsiveness. 
Kapp et al.  (1) and Benacerraf et al.  (2) have shown that suppressor, but not 
helper, cells are generated to synthetic antigens in genetic nonresponder mice. 
Thus,  these  systems of antibody responses to antigen  demonstrate  that  the 
generation  of helper and/or suppressor cells depends upon both the dosage of 
antigen,  as well as the genetic capability of the responding population.  The 
same factors appear to be critical  in the interaction  of the host with tumor. 
After tumor injection,  a  highly responsive strain  (AKB6F1) may develop only 
effector  mechanisms,  with  a  minimal,  if any,  degree  of suppression.  This 
would result in a successful (i.e., rejection) response. A less responsive strain 
(AKR/J), subjected to the identical tumor dose, may generate a greater degree 
of suppressive  activity,  and  therefore  approach  the  critical  equilibrium  be- 
tween positive and  negative factors which determines the overall success or 
failure  of the  response.  An  unresponsive  strain  (AKD2F~)  may  selectively 
produce only suppressors,  resulting  in progressive tumor growth.  It is note- 
worthy that the number and/or strength of these cells were found to increase 
as the tumor developed in the AKD2F1 animals.  Thus, it is possible that this 
strain  is genetically incapable  of generating  effector cells in response to the 
tumor examined. 
Such a  schema would also suggest that all responders could be subjected to 
some critical  tumor dosage,  large  enough  to induce  numbers  of suppressors 
able to shift the equilibrium to a state resulting in irreversible tumor growth. 
This is analogous to the finding that large doses of immunizing antigen lead to 
the generation  of suppressor cells responsible for the ensuing lack of specific 
antibody  production  (4).  Such  a  critical  dosage  would  vary for  each  tumor 
within  each  strain,  and  would decrease  as the  genetic  capability  of the  re- 
sponding host decreased.  Maintaining  the integrity  of the  organism  by suc- 
cessful rejection of tumor may, therefore,  depend on: (a) the genetic capabili- 
ties of the  host,  i.e.  immune  response genes  which  may control  anti-tumor 
responses,  as well as (b) the tumor burden,  dependent on the site of growth 
and the proliferative capacity of the neoplasm. 
Summary 
Parental  AKR/J,  and  AKB6F1  and  AKD2F~  hybrid  mice  were  injected 
subcutaneously with  a  spontaneously  arising  AKR/J tumor.  The  highly  re- 
sponsive AKB6F~ strain never exhibited any depression of immune function- 
ing during the course of tumor growth and regression. The (AKR/J) intermedi- 
ately  responsive  strain,  while  able to  generate  a  successful anti-tumor  re- 
sponse, did display a transient reduction of immunological capability, but only 
during the period of tumor growth and not during tumor regression. Cells able 
to suppress antibody, but not cell-mediated responses, were found. The unre- 
sponsive  AKD2F~  strain  was  characterized  by both a  marked  depression  of 
immune responsiveness, as well as the generation  of suppressor cells to both 
antibody,  and  later,  cell-mediated responses.  Depression of immune  respon- 
siveness, and the generation of suppressor cells, appeared to correlate with the 
strength or weakness of the anti-tumor  response in these strains  of mice. 1368  LEVY  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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